Windtree Therapeutics, Inc. /
Varian Biopharmaceuticals, Inc.
Windtree Therapeutics purchases Varian Biopharmaceuticals business assets




What happened
Windtree Therapeutics, Inc. purchased assets of Varian Biopharmaceuticals, Inc.’s business, including rights in molecules and compounds, know-how and drug-substance inventory associated with a licence agreement.
As consideration, Windtree issued 5,500 shares of Series B Convertible Preferred Stock to certain Varian creditors and agreed to pay up to $2,300,000 in milestone payments.
The source
Everything on this page comes from the source below.
Windtree Therapeutics purchases Varian Biopharmaceuticals business assets
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly